Inventor · disambiguated record
Hariharan Jayaram
Also filed as: JAYARAM HARIHARAN
12 granted patents·11 pending applications·27 citations·filing 2016–2025
87Inventor score
Top patents by PatentIndex Score
23 records- 0195US9963719B1Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNAEDITAS MEDICINE INC·Filed 2017·Granted May 8, 2018·15 cites·14 claims
- 0292US10006054B1Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNAEDITAS MEDICINE INC·Filed 2018·Granted Jun 26, 2018·6 cites·18 claims
- 0390US11236313B2Cas9 fusion molecules, gene editing systems, and methods of use thereofEDITAS MEDICINE INC·Filed 2017·Granted Feb 1, 2022·4 cites·14 claims
- 0486US12264331B2Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNAEDITAS MEDICINE INC·Filed 2023·Granted Apr 1, 2025·0 cites·26 claims
- 0584US11028411B2Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNAEDITAS MEDICINE INC·Filed 2019·Granted Jun 8, 2021·1 cites·28 claims
- 0678US11692205B2Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNAEDITAS MEDICINE INC·Filed 2021·Granted Jul 4, 2023·0 cites·6 claims
- 0773US12049651B2Cas9 fusion molecules, gene editing systems, and methods of use thereofEDITAS MEDICINE INC·Filed 2021·Granted Jul 30, 2024·0 cites·18 claims
- 0870US10494649B2Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNAEDITAS MEDICINE INC·Filed 2018·Granted Dec 3, 2019·0 cites·6 claims
- 0968US2024252543A1Crispr/cas-related methods and compositions for improving transplantationEDITAS MEDICINE INC·Filed 2023·Application pending·0 cites
- 1067US11180793B2Evaluation of Cas9 molecule/guide RNA molecule complexesEDITAS MEDICINE INC·Filed 2016·Granted Nov 23, 2021·1 cites·15 claims
- 1167US2024390520A1Gene editing of pcsk9 or angptl3 and compositions and methods of using same for treatment of diseaseVERVE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1262US2025320491A1Crispr-cpf1-related methods, compositions and components for cancer immunotherapyEDITAS MEDICINE INC·Filed 2025·Application pending·0 cites
- 1361US2022325326A1Evaluation of cas9 molecule/guide rna molecule complexesEDITAS MEDICINE INC·Filed 2021·Application pending·0 cites
- 1461US2024011023A1Hybridized guide nucleic acids for use with template-based gene editorsVERVE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1557US12325854B2Crispr-CPF1-related methods, compositions and components for cancer immunotherapyEDITAS MEDICINE INC·Filed 2018·Granted Jun 10, 2025·0 cites·9 claims
- 1655US2022002695A1Targeted active gene editing agent and methods of useSPOTLIGHT THERAPEUTICS·Filed 2021·Application pending·0 cites
- 1754US2022010337A1Targeted active gene editing agent and methods of useSPOTLIGHT THERAPEUTICS·Filed 2021·Application pending·0 cites
- 1850US2020299661A1Cpf1-related methods and compositions for gene editingEDITAS MEDICINE INC·Filed 2020·Application pending·0 cites
- 1947US11911415B2CRISPR/Cas-related methods and compositions for improving transplantationEDITAS MEDICINE INC·Filed 2016·Granted Feb 27, 2024·0 cites·27 claims
- 2039US2022033808A1Methods and compositions for nucleic acid-guided nuclease cell targeting screenSPOTLIGHT THERAPEUTICS·Filed 2021·Application pending·0 cites
- 2136US12286727B2Assessing nuclease cleavageEDITAS MEDICINE INC·Filed 2017·Granted Apr 29, 2025·0 cites·18 claims
- 2236US2016317632A1Use of cbp/ep300 bromodomain inhibitors for cancer immunotherapyGENENTECH INC·Filed 2016·Application pending·0 cites
- 2334US2023111575A1Synthetic guide molecules, compositions and methods relating theretoEDITAS MEDICINE INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hariharan Jayaram files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →